Therapy with the use of chimeric antigen receptor T-cell (CAR T-cells) is one most modern medical technologies in hemato-oncology, using, thanks to advances molecular biology, natural anti-cancer immune mechanisms. Nowadays, it an extremely effective complement conventional treatment and hematopoietic cell transplantation. Ongoing clinical trials show enormous potential this beyond hemato-oncol...